LAVA THERAPEUTICS N.V. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.89 USD | -0.34% |
|
-3.02% | +82.91% |
Chart calendar LAVA Therapeutics N.V.
077673f2e8f10d45c9baba.NZnlju-QJQHMmevh3RJ07f1Z_-NncsRfApwLXmy5o9Y.bLTStpvdSU2A1qelqiA3v5UBids0NqkKaaU5JlXTwYNk4KPPl-NncqvQug~189101be9a42abdf9a6531459507a706
Upcoming events on LAVA Therapeutics N.V.
Past events on LAVA Therapeutics N.V.
| 20/03/2024 11:00 | Q4 2023 Earnings Release |
| 16/11/2023 12:00 | Q3 2023 Earnings Release |
| 11/09/2023 12:00 | H.C. Wainwright Global Investment Conference |
| 22/08/2023 12:00 | Q2 2023 Earnings Release |
| 17/08/2023 15:00 | H.C. Wainwright Immune Cell Engager Conference |
| 14/06/2023 13:00 | Annual General Meeting |
| 08/06/2023 16:30 | Jefferies Global Healthcare Conference |
| 08/06/2023 12:00 | Q1 2023 Earnings Release |
| 11/04/2023 12:00 | Q4 2022 Earnings Release |
| 16/02/2023 19:30 | American Society of Clinical Oncology Genitourinary Cancers Symposium - Abstract #153 |
| 16/02/2023 18:00 | SVB Securities Global Biopharma Conference |
| 11/01/2023 18:30 | JP Morgan Healthcare Conference |
| 10/12/2022 22:30 | American Society of Hematology Meeting - Abstract #: 2014 |
| 17/11/2022 08:00 | Jefferies London Healthcare Conference |
| 16/11/2022 21:05 | Q3 2022 Earnings Release |
| 11/11/2022 14:00 | Society for Immunotherapy of Cancer Meeting - Abstract Number : 686 |
| 13/09/2022 21:05 | Interim 2022 Earnings Release |
| 12/09/2022 12:00 | H.C. Wainwright Global Investment Conference |
| 15/06/2022 06:30 | Annual General Meeting |
| 09/06/2022 16:30 | Jefferies Healthcare Conference - Fireside Chat |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 3,19 | 4,55 3,98 14.22% | 17,9 16,2 10.31% | 6,23 11,7 -46.77% | 3,23 |
|
EBITDA Million EUR | Released Forecast Spread | 0,00 | -40,0 -38,4 -4.22% | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million EUR | Released Forecast Spread | 0,00 | -40,3 -35,4 -13.96% | -32,1 -39,5 18.7% | -39,8 -44,6 10.76% | -40,2 |
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | 0,00 | -41,1 -39,0 -5.33% | -29,2 -32,4 9.81% | -38,4 -44,5 13.76% | -39,5 |
|
Net income Million EUR | Released Forecast Spread | -13,6 | -41,2 -37,3 -10.36% | -29,4 -33,7 12.65% | -38,6 -37,6 -2.93% | -38,4 |
|
EPS EUR | Released Forecast Spread | 0,00 | -2,09 -2,07 -0.87% | -1,13 -1,18 3.71% | -1,45 -1,43 -0.87% | -1,38 |
| Announcement Date | 02/03/21 | 24/03/22 | 11/04/23 | 20/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 0,91 0,38 139.21% | 0,95 0,51 86.52% | 0,47 0,32 46.77% | 14,7 10,6 38.85% | 2,43 0,23 944.67% | 1,14 0,00 - | 4,72 0,58 719.47% | 0,05 0,00 - | 0,33 5,80 -94.39% | 3,24 | 0,00 | 0,00 | 0,00 |
|
EBITDA Million EUR | Released Forecast Spread | -10,8 -13,6 20.95% | -1,35 -13,0 89.62% | |||||||||||
|
EBIT Million EUR | Released Forecast Spread | -8,90 -8,90 -0.01% | -10,3 -18,8 44.92% | -10,9 -16,4 33.52% | -1,45 -14,5 90.01% | -10,7 -17,0 37.29% | -12,6 -13,7 8.21% | -12,4 -13,3 6.35% | -9,87 -13,0 24.09% | -5,01 -10,4 51.77% | -7,34 | -11,3 | -12,1 | -12,9 |
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | -8,90 -10,0 10.98% | -9,96 -14,8 32.77% | -7,84 -13,6 42.48% | 1,00 -12,7 107.9% | -13,8 -16,2 14.9% | -12,9 -13,7 5.97% | -11,6 -13,3 12.87% | -8,09 -13,0 37.82% | -5,93 -10,9 45.37% | -7,06 | -11,0 | -11,8 | -12,6 |
|
Net income Million EUR | Released Forecast Spread | -8,95 -9,44 5.14% | -10,0 -17,7 43.37% | -7,92 -15,2 48% | 0,96 -3,41 128.11% | -13,8 -15,6 11.25% | -12,9 -13,7 5.49% | -11,7 -12,3 4.84% | -8,13 -12,1 33% | -5,98 -4,50 -33.1% | -7,06 | -11,0 | -11,8 | -12,6 |
|
EPS EUR | Released Forecast Spread | -0,35 -0,36 4.1% | -0,39 -0,77 49.43% | -0,31 -0,59 47.04% | 0,04 -0,14 127.78% | -0,53 -0,59 11.53% | -0,49 -0,48 -3.12% | -0,44 -0,46 4.05% | -0,31 -0,45 31.06% | -0,22 -0,11 -94.28% | -0,20 | -0,40 | -0,42 | -0,39 |
| Announcement Date | 24/03/22 | 17/05/22 | 13/09/22 | 16/11/22 | 11/04/23 | 08/06/23 | 22/08/23 | 16/11/23 | 20/03/24 | - | - | - | - |
More events
Past sector events for LAVA Therapeutics N.V.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- LVTX Stock
- Calendar LAVA Therapeutics N.V.
